Filter
873
Text search:
TB
drugs
Featured
Recommendations
82
New Publications
232
Language
Document type
No document type
600
Studies & Reports
93
Guidelines
87
Strategic & Response Plan
28
Manuals
24
Training Material
15
Fact sheets
13
Situation Updates
6
Infographics
4
Resource Platforms
3
Countries / Regions
India
62
Kenya
31
South Africa
31
Western and Central Europe
27
Malawi
23
Eastern Europe
21
Zambia
20
Nigeria
18
Ethiopia
18
Tanzania
18
Rwanda
18
Sierra Leone
16
Uganda
15
Africa
15
Global
15
Ukraine
13
Ghana
12
Nepal
12
Liberia
11
Philippines
11
Namibia
11
Lesotho
11
Bangladesh
10
Asia
10
Cambodia
8
Myanmar / Burma
8
South–East Asia Region
8
Botswana
7
Latin America and the Carribbean
7
Russia
7
Zimbabwe
6
Indonesia
5
Benin
5
Senegal
3
Germany
3
Syria
3
Peru
3
Eswatini/ Swaziland
3
Colombia
3
Paraguay
3
Tajikistan
3
Cameroon
2
Pakistan
2
Papua New Guinea
2
Brazil
2
East and Southern Africa
2
West and Central Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Southern Africa
2
Georgia
2
Guinea
1
Burkina Faso
1
Congo, Democratic Republic of
1
Haiti
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Singapore
1
Mozambique
1
Sudan
1
Argentina
1
Hungary
1
Ecuador
1
Sri Lanka
1
Yemen
1
Middle East and North Africa
1
Bhutan
1
Venezuela
1
Poland
1
Albania
1
Estonia
1
Moldova
1
Iran
1
Vietnam
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
385
Clinical Guidelines
79
Public Health
21
Women & Child Health
20
Key Resources
20
Capacity Building
8
Pharmacy & Technologies
7
Toolboxes
TB
191
HIV
151
AMR
41
COVID-19
18
Caregiver
17
Pharmacy
17
Mental Health
16
Refugee
12
NTDs
12
Conflict
7
Global Health Education
7
NCDs
7
Health Financing Toolbox
6
Disability
5
Ebola & Marburg
5
Polio
5
Natural Hazards
5
Planetary Health
4
Social Ethics
3
Rapid Response
2
Specific Hazards
2
2.0 Rapid Response
2
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to
...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
Plan Estratégico
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu
...
Em meados de 2021, os programas nacionais de SIDA começaram a fazer a transição do tratamento para crianças que vivem com VIH dolutegravir (DTG) 10 mg sulcado, comprimidos dispersíveis, também conhecido como DTG pediátrico (pDTG). A rápida introdução e implementação do pDTG é uma priori
...
Public Health Action
vol 5 no 3 published 21 september 2015
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Report of a mission 20–24 April 2015
Special summit of African Union on HIV and Aids, Tuberculosis and Malaria (atm) Abuja, Nigeria 2–4 may, 2006Sp/Assembly/ATM/2 (I), Rev.3
Abuja call for accelerated action towards universal access to HIV and Aids, Tuberculosis and Malaria services in Africa